Search Results for “aging” – Page 96 – media

Boosted by China launch, Merck’s Gardasil turns in a big first-quarter performance

Merck generated more than $1.5 billion in first-quarter vaccine sales. (Merck)
- Source: fiercepharma
- 584
- May 9, 2018
Gardasil HPV vaccine Merck
South-Indian states invite Midmark to set up unit

Midmark India, maker of medical equipment, is planning to set up its 15th center in the near future; the manufacturing unit is said to be set up in Andhra Pradesh or in Telengana.
- Source: Ddu
- 478
- May 8, 2018
Company Insights India medical device products
FDA approve iSchemaView’s 3D CTA

iSchemaView has received FDA approval for its latest product, RAPID CTA, a 3D imaging platform for computed tomography angiography (CTA).
- Source: drugdu
- 3,553
- May 4, 2018
digital health FDA imaging New Approvals
Three Tactics for Client Management

As a matter of fact, we all can better “manage” our clients.
- Source: drugdu
- 6,777
- May 4, 2018
Client Management Ddu College Tactics
Fitbit will use Google Cloud to make its data available to doctors

Fitbit announced yesterday that it plans to utilize Google’s new Cloud Healthcare API, in order to continue its push into the world of serious healthcare devices. It’s a bit of a no-brainer as far as partnerships go.
- Source: Tech Crunch
- 873
- May 2, 2018
Company Insights mHealth wearables
China hands out landmark nod with lightning speed

GSK’s Cervarix and Merck’s previous version of Gardasil took about 10 years to reach the Chinese market. (Merck)
- Source: fiercepharma
- 915
- May 2, 2018
CFDA Gardasil GSK New Approvals
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer

First Filing Acceptance for an Anti-PD-1 Therapy in Cervical Cancer
- Source: investors.merck
- 633
- May 2, 2018
cervical cancer FDA keytruda Merck
GSK reports Q1 sales decline

GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs. Profit after tax fell 38 percent to £759 million, while earnings per share dropped to 11.2p from 21.4p a year ago.
- Source: pharmatimes
- 494
- April 28, 2018
Company Insights GSK
As FDA’s Pre-Cert plan takes shape, worries emerge about overreach

Yesterday morning, the FDA published its 17-page first draft of a working model for its pre-certification program for software as a medical device (SaMD). Though still preliminary (the agency is asking for comments by the end of May), the publication comes with some long-awaited details about how the program might work.
- Source: MobiHealthNews
- 615
- April 27, 2018
FDA medical device products Policies
Third Rock Ventures Launches Cedilla Therapeutics with $56 Million Investment to Target Protein Stability Using Small Molecule Therapeutics

Company is targeting upstream aspects of native protein degradation pathways to develop new therapies for cancer
- Source: drugdu
- 703
- April 26, 2018
Market Views Series small molecule

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.